|
Re: Reports of Exempt Distribution
|
5
|
Zenith Epigenetics
|
Feb 09, 2023 08:01AM
|
|
Re: Comments on today's annual update
|
5
|
Resverlogix Corp.
|
Jun 23, 2021 06:34AM
|
|
Re: Voting reminder
|
5
|
Resverlogix Corp.
|
Jun 11, 2023 10:09AM
|
|
Re: Interesting.
|
5
|
Resverlogix Corp.
|
Nov 24, 2021 11:44AM
|
|
Re: Summary of ongoing and planned clinical trials
|
5
|
Zenith Epigenetics
|
Dec 23, 2020 08:49PM
|
|
Re: R & D
|
5
|
Resverlogix Corp.
|
Jul 30, 2019 12:34PM
|
|
Re: Is this bad for RVX but right, on the money?
|
5
|
Resverlogix Corp.
|
Apr 19, 2020 09:14PM
|
|
Re: Interesting Trades / Volume .....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 05:10AM
|
|
Re: Another Exempt Distribution -2022-06-02
|
6
|
Resverlogix Corp.
|
Jun 06, 2022 02:50PM
|
|
Re: Biotech Valuation
|
6
|
Resverlogix Corp.
|
Mar 31, 2021 07:06AM
|
|
Re: Stock price
|
6
|
Resverlogix Corp.
|
Apr 25, 2019 04:03PM
|
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
6
|
Zenith Epigenetics
|
Feb 28, 2022 09:29AM
|
|
Re: Your thoughts please
|
6
|
Resverlogix Corp.
|
Sep 04, 2024 01:00PM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
6
|
Zenith Epigenetics
|
Aug 20, 2020 08:14AM
|
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
6
|
Zenith Epigenetics
|
Jun 04, 2021 10:12AM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 17, 2022 09:38AM
|
|
Re: Is Resverlogix Legit?
|
6
|
Resverlogix Corp.
|
Jul 28, 2019 06:35AM
|
|
Re: Interesting.
|
6
|
Resverlogix Corp.
|
Nov 23, 2021 11:13AM
|
|
Re: Any day now......
|
6
|
Resverlogix Corp.
|
May 28, 2021 10:15PM
|
|
Re: Eversana ValuationCaseStudy
|
6
|
Resverlogix Corp.
|
Jan 09, 2022 12:20PM
|
